Logo image of MBOT

MICROBOT MEDICAL INC (MBOT) Stock Fundamental Analysis

USA - NASDAQ:MBOT - US59503A2042 - Common Stock

3.19 USD
+0.1 (+3.24%)
Last: 9/19/2025, 8:00:00 PM
3.14 USD
-0.05 (-1.57%)
Pre-Market: 9/22/2025, 5:22:41 AM
Fundamental Rating

3

Taking everything into account, MBOT scores 3 out of 10 in our fundamental rating. MBOT was compared to 190 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for MBOT as it has an excellent financial health rating, but there are worries on the profitability. MBOT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MBOT had negative earnings in the past year.
In the past year MBOT has reported a negative cash flow from operations.
In the past 5 years MBOT always reported negative net income.
MBOT had a negative operating cash flow in each of the past 5 years.
MBOT Yearly Net Income VS EBIT VS OCF VS FCFMBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -38.36%, MBOT is doing worse than 61.05% of the companies in the same industry.
MBOT has a Return On Equity (-41.86%) which is in line with its industry peers.
Industry RankSector Rank
ROA -38.36%
ROE -41.86%
ROIC N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
MBOT Yearly ROA, ROE, ROICMBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

MBOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBOT Yearly Profit, Operating, Gross MarginsMBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, MBOT has more shares outstanding
MBOT has more shares outstanding than it did 5 years ago.
MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBOT Yearly Shares OutstandingMBOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MBOT Yearly Total Debt VS Total AssetsMBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

MBOT has an Altman-Z score of 31.92. This indicates that MBOT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 31.92, MBOT belongs to the best of the industry, outperforming 97.37% of the companies in the same industry.
MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 31.92
ROIC/WACCN/A
WACCN/A
MBOT Yearly LT Debt VS Equity VS FCFMBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

MBOT has a Current Ratio of 12.06. This indicates that MBOT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MBOT (12.06) is better than 96.84% of its industry peers.
MBOT has a Quick Ratio of 12.06. This indicates that MBOT is financially healthy and has no problem in meeting its short term obligations.
MBOT's Quick ratio of 12.06 is amongst the best of the industry. MBOT outperforms 97.37% of its industry peers.
Industry RankSector Rank
Current Ratio 12.06
Quick Ratio 12.06
MBOT Yearly Current Assets VS Current LiabilitesMBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.06% over the past year.
EPS 1Y (TTM)18.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 28.66% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y53.14%
EPS Next 2Y28.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MBOT Yearly Revenue VS EstimatesMBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2025 2026 2M 4M 6M 8M 10M
MBOT Yearly EPS VS EstimatesMBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -200 -400 -600 -800

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MBOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MBOT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBOT Price Earnings VS Forward Price EarningsMBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBOT Per share dataMBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

MBOT's earnings are expected to grow with 28.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.66%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MBOT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MICROBOT MEDICAL INC

NASDAQ:MBOT (9/19/2025, 8:00:00 PM)

Premarket: 3.14 -0.05 (-1.57%)

3.19

+0.1 (+3.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-11 2025-11-11
Inst Owners8.88%
Inst Owner Change113.35%
Ins Owners1.47%
Ins Owner Change0%
Market Cap167.70M
Analysts82.86
Price Target12.24 (283.7%)
Short Float %14.24%
Short Ratio2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.79%
Min EPS beat(2)-22.55%
Max EPS beat(2)32.13%
EPS beat(4)1
Avg EPS beat(4)-3.67%
Min EPS beat(4)-22.55%
Max EPS beat(4)32.13%
EPS beat(8)5
Avg EPS beat(8)5.03%
EPS beat(12)9
Avg EPS beat(12)8.58%
EPS beat(16)10
Avg EPS beat(16)3.13%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)33.33%
PT rev (3m)33.33%
EPS NQ rev (1m)12.5%
EPS NQ rev (3m)22.22%
EPS NY rev (1m)0%
EPS NY rev (3m)15%
Revenue NQ rev (1m)-37%
Revenue NQ rev (3m)-68.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-72.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.52
P/tB 5.52
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.36%
ROE -41.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.16%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.06
Quick Ratio 12.06
Altman-Z 31.92
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)46.2%
Cap/Depr(5y)70.94%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.18%
EPS Next Y53.14%
EPS Next 2Y28.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.56%
OCF growth 3YN/A
OCF growth 5YN/A